| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLES |
Department of Biochemistry, Chang-Gung University, Taoyuan, Taiwan 333, Republic of China
Address all correspondence and requests for reprints to: Kwang-Huei Lin, Department of Biochemistry, Chang-Gung University, 259 Wen-hwa 1 Road, Taoyuan, Taiwan, Republic of China. E-mail: khlin{at}mail.cgu.edu.tw
Thyroid hormone (T3) exerts its many biological activities
through interaction with specific nuclear receptors (TRs) that function
as ligand-dependent transcription factors at genes that contain a
thyroid hormone response element (TRE). Mutant TRs have been detected
in human hepatocellular carcinoma cell lines and tissue, but their
contribution to carcinogenesis has remained unclear. The interaction of
four such mutant TRs (J7-TR
1, J7-TRß1, H-TR
1, and
L-TR
1) with transcriptional coregulators has now been
investigated. With the exception of J7-TR
1, which in the absence of
T3 exhibited transcriptional silencing activity with a
TRE-reporter gene construct in transfected cells, the mutant TRs had
little effect (compared with that of wild-type receptors) on
transcriptional activity of the reporter gene in the absence or
presence of T3, of the transcriptional corepressors SMRT,
NCoR or of the transcriptional coactivator SRC. Electrophoretic
mobility-shift assays revealed that, in the presence of T3,
the J7-TRß1 mutant did not interact with SRC, whereas J7-TR
1
and H-TR
1 exhibited reduced abilities to associate with this
coactivator and L-TR
1 showed an ability to interact with
SRC similar to that of wild-type TR
1. The dominant negative activity
of the mutant TRs in transfected cells appeared inversely related to
the ability of the receptors to interact with SRC. Whereas
J7-TRß1, H-TR
1, and L-TR
1 did not interact with
SMRT, and NCoR. J7-TR
1 bind to corepressors but failed to dissociate
from them in the presence of T3. These aberrant
interactions between the mutant TRs and transcriptional coregulators
may contribute to the highly variable clinical characteristics of human
hepatocellular carcinoma.
This article has been cited by other articles:
![]() |
S. L. Chen, Y. J. Chang, Y. H. Wu, and K. H. Lin Mitogen-Activated Protein Kinases Potentiate Thyroid Hormone Receptor Transcriptional Activity by Stabilizing Its Protein Endocrinology, April 1, 2003; 144(4): 1407 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M. C. Willingham, and S.-y. Cheng A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice PNAS, November 29, 2001; (2001) 261565798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M. C. Willingham, and S.-y. Cheng A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice PNAS, December 18, 2001; 98(26): 15095 - 15100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |